Skip to content

Study on the effectiveness and safety of Mingyue anti-fatigue lens to relieving visual fatigue

Study on the effectiveness and safety of Mingyue anti-fatigue lens to relieving visual fatigue

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086419
Enrollment
Unknown
Registered
2024-07-01
Start date
2023-11-05
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual fatigue

Interventions

Trial Group:Wear anti-fatigue frame glasses (bright moon anti-fatigue lenses)
Control Group:Wear ordinary frame glasses (optical single focal lens)

Sponsors

Wenzhou Eye Valley Super Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1) Age of 35-45 years old, without gender limitation; 2) Diopter range: + 8.00D ~ -13.00D; 3) Anisometropia = 2.00D; 4) Astigmatism = 2.50D; 5) Best corrected visual acuity (international standard log visual acuity), monocular = 5.0; 6) Tear film rupture time = 5S; 7) No other organic lesions in both eyes; 8) The Subjects understood the purpose of the trial, were enrolled voluntarily and followed randomization, signed the informed consent, and completed all ophthalmic examinations after enrollment.

Exclusion criteria

Exclusion criteria: 1) Patients with glaucoma, cataract and other eye diseases; visual abnormalities in both eyes, including congenital color vision disorders (color blindness); 2) No obvious abnormal binocular visual function; 3) Evaluated by researchers, other ocular abnormalities in both eyes that may affect the observation results, including nystagmus, eye injury, corneal, conjunctival or eyelid disease, fundus lesions, photophobia or failure to open eyes normally; 4) Other systemic diseases, such as Marfan syndrome; 5) Previous ophthalmic surgery (including strabismus surgery).

Design outcomes

Primary

MeasureTime frame
Visual fatigue scale;

Secondary

MeasureTime frame
Amplitude of Accommodation;Near points of convergence;

Countries

China

Contacts

Public ContactQu Jia

Wenzhou Eye Valley Super Eye Hospital

wanghognbio@wmu.edu.cn+86 158 6962 7916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026